FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2039190147> ?p ?o ?g. }

• W2039190147 endingPage "758" @default.
• W2039190147 startingPage "753" @default.
• W2039190147 abstract "Chronic inflammation represents one of the hallmarks of cancer. Of special relevance to the malignant process is the pro-inflammatory cytokine IL-1 playing a crucial role in cancer-related inflammation. Recent observations indicate increased IL-1 levels in an animal model of human osteosarcoma, the most frequent primary malignant bone tumor in man. In patients with bone sarcomas, increased serum levels of tumor-promoting cytokines, including IL-6, IL-8 and VEGF can be found, correlating with poor overall survival. The link between cancer and inflammation makes it clear that there is a need to reduce the external factors inducing inflammation as a preventive or therapeutical measure. Therefore, in the present study the effects of anti-inflammatory IL-1 receptor antagonist (IL-1Ra) was tested alone and in combination with (-)-epigallocatechin-3-gallate (EGCG), an anti-inflammatory chemopreventive agent from green tea, on the production of IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells. We found that IL-1Ra and EGCG downregulated IL-1-induced IL-6 and IL-8 release from U-2 OS cells by 65-85%. IL-1Ra and EGCG also reduced secretion of invasiveness-promoting MMP-2 and pro-angiogenic VEGF to 62-75% without affecting the metabolic response and caspase-3 activity. In conclusion, downregulation of IL-1-induced tumorigenic factors (IL-6, IL-8, VEGF, MMP-2) in U-2 OS by IL-1Ra and EGCG may positively affect tumor-associated inflammation and, as a consequence, lead to reduction in angiogenesis and invasiveness. This renders a combined administration of EGCG and IL-1Ra a promising approach as an adjuvant therapy in patients with osteosarcoma." @default.
• W2039190147 created "2016-06-24" @default.
• W2039190147 creator A5020400956 @default.
• W2039190147 creator A5062462425 @default.
• W2039190147 creator A5083078836 @default.
• W2039190147 date "2012-05-28" @default.
• W2039190147 modified "2023-09-30" @default.
• W2039190147 title "Combined administration of EGCG and IL-1 receptor antagonist efficiently downregulates IL-1-induced tumorigenic factors in U-2 OS human osteosarcoma cells" @default.
• W2039190147 cites W113373895 @default.
• W2039190147 cites W1515994079 @default.
• W2039190147 cites W1896985636 @default.
• W2039190147 cites W1965607649 @default.
• W2039190147 cites W1966517854 @default.
• W2039190147 cites W1968130822 @default.
• W2039190147 cites W1977884267 @default.
• W2039190147 cites W1984752955 @default.
• W2039190147 cites W1999797961 @default.
• W2039190147 cites W2001291822 @default.
• W2039190147 cites W2004447523 @default.
• W2039190147 cites W2007043238 @default.
• W2039190147 cites W2009216493 @default.
• W2039190147 cites W2017471544 @default.
• W2039190147 cites W2018433301 @default.
• W2039190147 cites W2019663874 @default.
• W2039190147 cites W2028979122 @default.
• W2039190147 cites W2038927253 @default.
• W2039190147 cites W2044261235 @default.
• W2039190147 cites W2045811396 @default.
• W2039190147 cites W2050249291 @default.
• W2039190147 cites W2059764571 @default.
• W2039190147 cites W2074639500 @default.
• W2039190147 cites W2079588482 @default.
• W2039190147 cites W2083239828 @default.
• W2039190147 cites W2083271091 @default.
• W2039190147 cites W2088768592 @default.
• W2039190147 cites W2092521895 @default.
• W2039190147 cites W2104729679 @default.
• W2039190147 cites W2105267820 @default.
• W2039190147 cites W2114918609 @default.
• W2039190147 cites W2123105952 @default.
• W2039190147 cites W2133439754 @default.
• W2039190147 cites W2134841682 @default.
• W2039190147 cites W2139520473 @default.
• W2039190147 cites W2140432305 @default.
• W2039190147 cites W2146473087 @default.
• W2039190147 cites W2149374693 @default.
• W2039190147 cites W2152835156 @default.
• W2039190147 cites W2153663340 @default.
• W2039190147 cites W2168026945 @default.
• W2039190147 cites W2315613727 @default.
• W2039190147 cites W4246742253 @default.
• W2039190147 cites W4293247451 @default.
• W2039190147 doi "https://doi.org/10.3892/ijo.2012.1498" @default.
• W2039190147 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22641358" @default.
• W2039190147 hasPublicationYear "2012" @default.
• W2039190147 type Work @default.
• W2039190147 sameAs 2039190147 @default.
• W2039190147 citedByCount "20" @default.
• W2039190147 countsByYear W20391901472012 @default.
• W2039190147 countsByYear W20391901472013 @default.
• W2039190147 countsByYear W20391901472014 @default.
• W2039190147 countsByYear W20391901472015 @default.
• W2039190147 countsByYear W20391901472016 @default.
• W2039190147 countsByYear W20391901472018 @default.
• W2039190147 countsByYear W20391901472019 @default.
• W2039190147 countsByYear W20391901472020 @default.
• W2039190147 countsByYear W20391901472022 @default.
• W2039190147 countsByYear W20391901472023 @default.
• W2039190147 crossrefType "journal-article" @default.
• W2039190147 hasAuthorship W2039190147A5020400956 @default.
• W2039190147 hasAuthorship W2039190147A5062462425 @default.
• W2039190147 hasAuthorship W2039190147A5083078836 @default.
• W2039190147 hasBestOaLocation W20391901471 @default.
• W2039190147 hasConcept C104317684 @default.
• W2039190147 hasConcept C121608353 @default.
• W2039190147 hasConcept C126322002 @default.
• W2039190147 hasConcept C127561419 @default.
• W2039190147 hasConcept C170493617 @default.
• W2039190147 hasConcept C203014093 @default.
• W2039190147 hasConcept C2776885963 @default.
• W2039190147 hasConcept C2776914184 @default.
• W2039190147 hasConcept C2777760704 @default.
• W2039190147 hasConcept C2778122271 @default.
• W2039190147 hasConcept C2778690821 @default.
• W2039190147 hasConcept C2780394083 @default.
• W2039190147 hasConcept C2781018059 @default.
• W2039190147 hasConcept C29537977 @default.
• W2039190147 hasConcept C502942594 @default.
• W2039190147 hasConcept C55493867 @default.
• W2039190147 hasConcept C71924100 @default.
• W2039190147 hasConcept C74172505 @default.
• W2039190147 hasConcept C86803240 @default.
• W2039190147 hasConceptScore W2039190147C104317684 @default.
• W2039190147 hasConceptScore W2039190147C121608353 @default.
• W2039190147 hasConceptScore W2039190147C126322002 @default.
• W2039190147 hasConceptScore W2039190147C127561419 @default.
• W2039190147 hasConceptScore W2039190147C170493617 @default.
• W2039190147 hasConceptScore W2039190147C203014093 @default.

• next